SUMMARY The effectiveness of a single oral dose of ciprofloxacin in eradicating urethral gonorrhoea was assessed in 18 men who received 250 mg and 26 men who were given 100 mg. All patients, including two infected with lactamase (penicillinase) producing strains of Neisseria gonorrhoeae (PPNG), were cured. The drug had no effect on infection with Chiamydia trachomatis or on the incidence of post gonococcal urethritis. Ciprofloxacin may be useful in patients hypersensitive to penicillins and cephalosporins, and the drug may also be useful in urethral gonorrhoea caused by PPNG strains.
Introduction
With the increasing incidence of antimicrobial resistance among isolates of Neisseria gonorrhoeae it is important to continue to examine new compounds. Ciprofloxacin is an orally active quinolone carboxylic acid derivative related to nalidixic acid. The We asked all patients to attend again at one, seven and 14 days after treatment. At each visit, they were examined, and urethral smears were collected for microscopy and culture for Ngonorrhoeae. Throat and rectal cultures for N gonorrhoeae were performed as appropriate. Cultures for Chiamydia trachomatis were obtained before treatment from all patients, and also seven and 14 days after treatment from patients treated with 250 g ciprofloxacin. Blood was taken for full haematological and biochemical screening before and one day after treatment.
We measured minimum inhibitory concentrations (MICs) of penicillin and ciprofloxacin against 33 isolates. All organisms requiring MICs of penicillin of over 0 25 mg/l were assessed for B lactamase production.' Postgonococcal urethritis (PGU) was diagnosed when C trachomatis cultures were positive, or 10 or more white blood cells per high power field were seen in the urethral smears 14 days after treatment. None of the patients reported any side effects to ciprofloxacin. Two patients treated with each dose had a slight rise in serum aspartate aminotransferase activity. All other biochemical and haematological variables were unaffected by the drug.
Results

Discussion
The study reported here shows that ciprofloxacin as a single oral dose of 100 mg or 250 mg is effective in eradicating urethral gonorrhoea in men. The drug is not associated with any side effects or adverse reactions. Studies performed in male volunteers given single oral doses of 250 mg to 1000 mg or multiple doses ranging from 500 mg to 1500 mg daily have shown no adverse reactions. The drug achieves a maximum serum concentration of 0-8 to 1 2 mg/I after an oral dose of 250 mg, which is over 100 times more than the MIC.4 Serum half life after after this dose of ciprofloxacin is about four hours,5 and the drug has good tissue penetration.
A single dose of ciprofloxacin had no effect on chlamydial infection or the incidence of PGU. A related compound, norfloxacin, has shown equal 87 
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